Abstract
The photoacoustic imaging (PAI) system is an emerging imaging modality that can be useful in clinical diagnostic testing. Previous studies have shown utility of PAI in diagnosing breast cancer, visualizing vascular change in ageing, and planning flap reconstruction surgeries. In this study, we show that PAI can be used to non-invasively visualize microvascular injuries in smokers, and in a vasculitis patient.
We used two prototype PAI systems, PAI-03, and PAI-04 in this study. These systems were equipped with hemisphere-detector arrays, and used lasers at wavelengths of 795 nm (PAI-03), 756 and 797nm (PAI-04). Healthy volunteers and a patient diagnosed with vasculitis were enrolled upon obtaining written informed consent. The whole hand of the volunteers was scanned.
We noted there were unique circular structures that we coined “minute signals”. There were higher number of minute signals in smokers than in non-smokers. Enhanced minute signals were noted in the patient with vasculitis. In this patient, minute signals were suggested to have lower oxygenated hemoglobin content, likely suggesting blood clots or hemorrhage. Our study shows PAI systems can visualize unappreciated abnormalities in fine vasculatures non-invasively. Use of PAI can extend to other clinical entities with suspected vascular involvement.
Competing Interest Statement
Y. Asao and T. Yagi are employees of Luxonus Ltd.. PAI-03 and PAI-04 were provided by Canon.
Funding Statement
This work was funded by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the internal review board of Kyoto University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Present affiliation is Luxonus Inc.
Data Availability
Relevant data are provided upon reasonable request.
